Efficacy and safety of levosimendan in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial
Levosimendan is a safe and effective therapeutic option for reducing infarct size in patients with STEMI.
Authors
- Alejandro Jiménez (ORCID: https://orcid.org/0000-0001-8732-2616)
- Geoffrey Yanes Bowden
- Consuelo Rodríguez Jiménez (ORCID: https://orcid.org/0009-0007-6988-670X)
- Michele Fraga de Santana (ORCID: https://orcid.org/0000-0002-5557-260X)
- Corabel Méndez Vargas (ORCID: https://orcid.org/0000-0001-5420-7750)
- María Manuela Izquierdo Gómez
- Francisco Bosa Ojeda
- Alejandro Sánchez‐Grande Flecha
- Juan Almeida
Institutions
- Hospital Universitario de Canarias (ES)
- Hospital Universitario Nuestra Señora de Candelaria (ES)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1002/ccd.31267
- Citations
- 1
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.40